Phathom Pharmaceuticals, Inc. (PHAT) stock
PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.06−0.17 (-2.73%)
Close on Nov 13, 2026Market cap $492.63MP/E –Yield –
Phathom Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Phathom Pharmaceuticals's cash was $184.56M at Sep 30, 2026. For fiscal 2025 it was $129.97M, down 56.3% from the year before. The highest annual figure on record is $381.39M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $129.97M | -56.3% |
| FY2024 | Dec 31, 2024 | $297.26M | -22.1% |
| FY2023 | Dec 31, 2023 | $381.39M | +145.5% |
| FY2022 | Dec 31, 2022 | $155.39M | -15.2% |
| FY2021 | Dec 31, 2021 | $183.26M | -36.3% |
| FY2020 | Dec 31, 2020 | $287.50M | +17.9% |
| FY2019 | Dec 31, 2019 | $243.77M | +27632.1% |
| FY2018 | Dec 31, 2018 | $879.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $184.56M | +36.6% |
| Q2 FY2026 | Jun 30, 2026 | $182.48M | +22.0% |
| Q1 FY2026 | Mar 31, 2026 | $180.90M | -14.8% |
| Q4 FY2025 | Dec 31, 2025 | $129.97M | -56.3% |
| Q3 FY2025 | Sep 30, 2025 | $135.16M | -59.6% |
| Q2 FY2025 | Jun 30, 2025 | $149.57M | -45.9% |
| Q1 FY2025 | Mar 31, 2025 | $212.32M | -34.1% |
| Q4 FY2024 | Dec 31, 2024 | $297.26M | -22.1% |
| Q3 FY2024 | Sep 30, 2024 | $334.68M | +56.6% |
| Q2 FY2024 | Jun 30, 2024 | $276.24M | +11.0% |
| Q1 FY2024 | Mar 31, 2024 | $322.23M | +148.7% |
| Q4 FY2023 | Dec 31, 2023 | $381.39M | +145.5% |
| Q3 FY2023 | Sep 30, 2023 | $213.68M | +8.6% |
| Q2 FY2023 | Jun 30, 2023 | $248.85M | +20.0% |
| Q1 FY2023 | Mar 31, 2023 | $129.57M | -6.2% |
| Q4 FY2022 | Dec 31, 2022 | $155.39M | -15.2% |
| Q3 FY2022 | Sep 30, 2022 | $196.84M | -12.4% |
| Q2 FY2022 | Jun 30, 2022 | $207.39M | -1.1% |
| Q1 FY2022 | Mar 31, 2022 | $138.09M | -42.0% |
| Q4 FY2021 | Dec 31, 2021 | $183.26M | -36.3% |
| Q3 FY2021 | Sep 30, 2021 | $224.62M | -0.8% |
| Q2 FY2021 | Jun 30, 2021 | $209.67M | -15.2% |
| Q1 FY2021 | Mar 31, 2021 | $237.97M | -7.3% |
| Q4 FY2020 | Dec 31, 2020 | $287.50M | +17.9% |
| Q3 FY2020 | Sep 30, 2020 | $226.36M | +203.9% |
| Q2 FY2020 | Jun 30, 2020 | $247.27M | +28030.9% |
| Q1 FY2020 | Mar 31, 2020 | $256.67M | – |
| Q4 FY2019 | Dec 31, 2019 | $243.77M | – |
| Q3 FY2019 | Sep 30, 2019 | $74.48M | – |
| Q4 FY2018 | Dec 31, 2018 | $879.00K | – |
See a number that looks wrong?